Michael Pinho

Michael Pinho is an Associate Director at BioNTech SE since May 2022, previously holding positions at Bristol Myers Squibb and Celgene in clinical trial management roles focusing on Hematology/Oncology. With a background in Biology, Michael has a Master's degree in Clinical Trial Sciences from Rutgers University and has experience managing various clinical trials in areas such as AML, MDS, DLBCL, and MF. Prior to their current role, Michael worked as a Graduate Teaching Assistant at Rutgers University and held positions at Ipsen, ImClone Systems, and Merck/Schering-Plough Pharmaceuticals. Throughout their career, Michael has provided strategic and operational leadership to ensure the success of clinical studies in compliance with regulations and guidelines.